Lysyl oxidase‐like 2 promotes stemness and enhances antitumor effects of gefitinib in head and neck cancer via IFIT1 and IFIT3

Lysyl oxidase‐like 2 (LOXL2) is a matrix‐remodeling enzyme that has recently been identified as an important regulator of tumor progression and metastasis. This study discovered that LOXL2 expression in oral squamous cell carcinoma (OSCC) tissues was significantly associated with tumor clinical stag...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yi‐Jie, Deng, Yi‐Ting, Ko, Hui‐Hsin, Peng, Hsin‐Hui, Lee, Hsiang‐Chieh, Kuo, Mark Yen‐Ping, Cheng, Shih‐Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551584/
https://www.ncbi.nlm.nih.gov/pubmed/37496288
http://dx.doi.org/10.1111/cas.15912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551584/
https://www.ncbi.nlm.nih.gov/pubmed/37496288
http://dx.doi.org/10.1111/cas.15912

Ejemplares similares